Newcastle upon Tyne, United Kingdom

Rachael Dixon



 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rachael Dixon: Innovator in Bio-Macromolecule Separation

Introduction

Rachael Dixon, an accomplished inventor based in Newcastle upon Tyne, Great Britain, has made significant contributions to the field of biotechnology. She holds a patent that showcases her innovative approach to separating bio-macromolecules, a pivotal technique in the extraction of DNA from complex mixtures.

Latest Patents

Rachael's patent, titled "Sorbent Material for Separating Bio-Macromolecules," provides a solution for one-step extraction of DNA. This invention presents a sorbent material comprising a silanized surface that is at least partially coated with various polymers, including poly(aryl methacrylate), poly(aryl acrylate), and other specialized copolymers. This advancement simplifies the extraction process, making it an essential tool in molecular biology.

Career Highlights

Rachael Dixon is currently associated with QuantumDX Group Limited, a company known for its cutting-edge work in diagnostic technologies. Her unique blend of scientific expertise and innovative thinking has positioned her as an influential figure in her field. With her focus on practical applications of her inventions, Rachael has been able to address real-world challenges in biotechnology.

Collaborations

Throughout her career, Rachael has collaborated with prominent colleagues including Jonathan James O’Halloran and Joseph H Hedley. These partnerships have enhanced her projects and fostered a collaborative atmosphere conducive to groundbreaking research and development.

Conclusion

Rachael Dixon exemplifies the spirit of innovation in biotechnology. Her patent on sorbent materials for the separation of bio-macromolecules demonstrates her commitment to advancing scientific knowledge and improving extraction techniques in molecular biology. As she continues her work with QuantumDX Group Limited, the potential for future innovations remains promising.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…